InsiderTrades

Form 4 for GILD Gilead Sciences

Accepted 2025-02-06 00:00:00 ET · period of report 2025-02-04 · accession 0001127602-25-003362 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2025-02-06 2025-02-04 GILD Dickinson Andrew D CFO F - Tax $97.99 -43.1K 171.2K -20% -$4.23M
M 2025-02-06 2025-02-04 GILD Dickinson Andrew D CFO A - Grant $0.00 +84.5K 149.7K +130% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-02-04 F D 43,138 $97.99 171,223 D — —
2 Common Common Stock 2025-02-04 A A 64,695 $0.00 214,361 D — — (F2) Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on March 10, 2022. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors.
3 Common Common Stock 2025-02-04 A A 19,793 $0.00 149,666 D — — (F1) Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2023 and March 10, 2024. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met.